ENTRECTINIB | N212725 | GENENTECH INC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8299057 | Mar 10, 2032 | — | Yes | Yes | — | — |
| 8673893 | Jul 8, 2028 | — | — | — | — | |
| 9029356 | Jul 8, 2028 | — | Yes | Yes | — | — |
| 9085558 | Jul 8, 2028 | — | — | Yes | — | — |
| 9085565 | May 22, 2033 | — | Yes | Yes | — | — |
| 9255087 | Jul 8, 2028 | — | — | — | — | |
| 9616059 | Jul 8, 2028 | — | — | — | — | |
| 9649306 | May 22, 2033 | — | — | — | — | |
| 10231965 | Feb 17, 2035 | — | — | — | — | |
| 10398693 | Jul 18, 2038 | — | — | Yes | — | — |
| 10561651 | Feb 19, 2035 | — | — | — | — | |
| 10738037 | May 18, 2037 | — | Yes | Yes | — | |
| 11091469 | May 18, 2037 | — | — | — | — | |
| 11253515 | Jul 18, 2038 | — | — | Yes | — | — |
| Code | Date | Status |
|---|---|---|
| NPP | Oct 20, 2026 | < 1 year |
| ODE-265 | Aug 15, 2026 | < 1 year |
| ODE-313 | Aug 15, 2026 | < 1 year |
| ODE-448 | Oct 20, 2030 | Active |